Navigation Links
Xoft Announces Exclusive Contract With Premier for Electronic Brachytherapy
Date:7/15/2010

SUNNYVALE, Calif., July 15 /PRNewswire/ -- Premier Inc., an alliance of more than 2,300 U.S. hospitals and 67,000-plus other healthcare sites working together to achieve high quality, cost-effective care, and Xoft, Inc., the leading provider of FDA-cleared Electronic Brachytherapy Systems, announced the execution of a group purchasing contract.  Xoft was awarded an exclusive three-year contract for brachytherapy systems with Premier Purchasing Partners L.P., the group purchasing unit of Premier, Inc.  The agreement, which is in effect through May 1, 2013 extends Premier members preferred pricing on Xoft's Axxent Electronic Brachytherapy System for use for the treatment of breast, endometrial, and skin cancers.

"Premier has a proven track record of providing the latest advances in women's health, and we want to thank the Imaging and Radiation Oncology Committee for offering its members access to this important cancer treatment platform that delivers definitive treatment directly to the cancer tumor with minimal exposure to surrounding healthy tissues," said Michael Klein, president and CEO of Xoft.  "This is yet another validation of both the clinical value of isotope-free electronic treatment for accelerated brachytherapy and IORT applications that has been strongly reinforced recently by multiple publications, including the recent TARGIT study."  

Available for treatment of early stage breast cancer, endometrial cancer, and skin cancer, the Axxent eBx System is also FDA cleared for use in the treatment of surface cancers or conditions where radiation therapy is indicated, including IORT (intraoperative radiation therapy). As a platform technology, the Axxent System is designed to deliver non-radioactive therapy directly to cancerous tissue with minimal radiation exposure to surrounding healthy tissue. Utilizing a proprietary miniaturized X-ray source and robotic controller, treatment can be performed in minimally shielded therapeutic settings allowing the radiation oncologist and other medical personnel to be present during treatment delivery and minimizing patient anxiety.

"Innovations such as Electronic Brachytherapy can clearly support Premier's goals of improving healthcare quality and affordability, and we look forward to working with Premier's members to improve access to this safe effective cancer treatment that can be delivered in a more patient friendly environment than traditional isotope-based therapies that require shielded rooms," Klein added.

About Premier Inc., 2006 Malcolm Baldrige National Quality Award recipient

The Premier healthcare alliance is more than 2,300 U.S. hospitals and 67,000-plus other healthcare sites working together to improve healthcare quality and affordability. Owned by not-for-profit hospitals, Premier maintains the nation's most comprehensive repository of clinical, financial and outcomes information and operates a leading healthcare purchasing network. A world leader in helping deliver measurable improvements in care, Premier works with the Centers for Medicare & Medicaid Services and the United Kingdom's National Health Service North West to improve hospital performance. Headquartered in Charlotte, N.C., Premier also has offices in San Diego, Philadelphia and Washington.

About Xoft, Inc.

Xoft develops Electronic Brachytherapy (eBx) systems based upon miniaturized X-ray tube technology for the practice of radiation oncology in virtually any clinical setting, eliminating the need for heavily shielded environments. The Axxent® treatment platform provides a therapeutic dose of radiation directly to the region at risk with minimal radiation exposure to surrounding healthy tissue and without the logistics and costs associated with using radioactive isotopes.  Available for treatment of early stage breast cancer, skin cancer and endometrial cancer, the Axxent System is also cleared for use in the treatment of other cancers or conditions where radiation therapy is indicated. For information, visit www.xoftinc.com.

Axxent is a registered trademark and eBx is a trademark of Xoft, Inc.


'/>"/>
SOURCE Xoft, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Draeger Announces Partnership With L. N. Curtis & sons to Distribute Emergency Responder Equipment
2. Hill-Rom Announces Executive Appointments
3. China Medical Technologies Announces the Use of its HER-2 FISH Probe in a Cancer Targeted Therapy Research Project Sponsored by the Chinese Ministry of Health
4. ThromboGenics Announces Publication of Positive Microplasmin Phase II Data in the Journal Retina
5. RoundTable Healthcare Partners Announces Sale of Bioniche Pharma Holdings Limited to Mylan Inc.
6. EnVivo Pharmaceuticals Announces Significant Results from GSM Transgenic Mouse Model for Alzheimers Disease
7. Kendle Announces Details Regarding Second Quarter 2010 Earnings Conference Call and Webcast
8. Havels Incorporated Announces the Release of Four New Innovative Ultrasound Needles
9. Amira Announces AM103 and AM803 Patent Grant in the United Kingdom
10. Hanger Orthopedic Group, Inc. Announces Second Quarter 2010 Earnings Release Conference Call
11. K-V Pharmaceutical Announces Resubmission to New Drug Application for Gestiva™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):